This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Northwestern University for $250,000 to provide medical record abstraction services for a study comparing pediatric cancer patients treated with proton versus photon radiation therapy. The services will be performed remotely, and the period of performance is a 14-month base period starting around November 1, 2024. This requirement was competed under simplified acquisition procedures without a set-aside...
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
The National Cancer Institute (NCI) awarded a $249,814 firm fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to establish the US Pediatric Proton and Photon Therapy Cohort. This retrospective cohort study will compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
This is a $250,000.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Baylor College of Medicine for the US Pediatric Proton and Photon Therapy Cohort study. The contract, which has no set-aside designation, requires Baylor to retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric cancer patients treated with proton or photon therapy at their institution. This data will be used to evaluate the risks and benefits of...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, for $252,134 to provide medical record abstraction services for a pediatric proton and photon therapy comparison cohort study. The 14-month contract has an anticipated start date of November 1, 2024. The services will be performed remotely by Mayo Clinic Arizona, which has an extensive history as a prime contractor delivering diagnostic and...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit hospital and research institution. The $249,997.00 contract will obtain data on a cohort of pediatric cancer patients treated with proton therapy and a comparison group treated with photon therapy, to serve as part of a...
This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. The $624,994 contract will run from September 2024 to March 2027. The contractor will assemble existing data from medical records for a group of pediatric cancer patients...
This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to The Ohio State University to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The $243,347.00 contract has a completion date of September 14, 2023. The Ohio State University, a public research university, will retrieve existing medical record data on...